Inside informationEnglish
Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Transgene S.A.
- Filed
- 20/10/2025, 08:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 113713_20251020